Cat.#: ACPP-1656
| Despition | MAPT Human Recombinant |
| SIZE | 2 µg |
| Purity | > 85.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1276 | MAP3K4 Blocking Peptide (AC1276) | 250 µg | inquiry |
| ACPP-1123 | Recombinant Rat GFAP Protein (AC1123) | 25 µl | inquiry |
| ACPP-1323 | FYN Blocking Peptide (AC1323) | 250 µg | inquiry |
| ACPP-1340 | PDE7A Blocking Peptide (AC1340) | 250 µg | inquiry |
| ACPP-1500 | Mouse PEBP1 Protein (AC1500) | 5 µg | inquiry |
| ACPP-1199 | Beta crystallin S Blocking Peptide (AC1199) | 250 µg | inquiry |
| ACPP-1686 | Human Acrp30 Protein, HEK (AC1686) | 2 µg | inquiry |
| ACPP-1703 | Human PITPNA Protein (AC1703) | 5 µg | inquiry |
| ACPP-1647 | Human TUBB3 Protein (AC1647) | 2 µg | inquiry |
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.